MedTrace Logo

Alveolar Management Following Teeth Extraction

NCT03089619 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-07-17

No results posted yet for this study

Summary

Investigation of the volume stability of the alveolar ridge, the bone structure and soft tissue appearance at a delayed dental implantation using two bone substitute materials (1. Human-Spongiosa, gefriergetrocknet, CHB; 2. collacone®)

Conditions

  • Alveolar Bone Loss
  • Bone Resorption

Interventions

DRUG

Human-Spongiosa

after tooth extraction, the dental alveolus is filled with the bone substitute material (Human-Spongiosa) and covered with a membrane (mucoderm®)

DEVICE

collacone®

after tooth extraction, the dental alveolus is filled with the bone substitute material (collacone®) and covered with a membrane (mucoderm®)

Sponsors & Collaborators

  • Botiss Medical AG

    collaborator OTHER

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Stefan Engeli, Prof. · University Greifswald, KKS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-02
Primary Completion
2022-01-14
Completion
2023-05-08

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089619 on ClinicalTrials.gov